Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
Ophthalmic Plastic and Reconstructive Surgery|April 16, 2024
Composite Histiocytic Sarcoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma of the Ocular AdnexaChenxu Shi, Andrew Lytle, Tatyana Milman, et al.
The American Journal of Surgical Pathology|January 5, 2002
Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphomaJianguo Tao, Suresh G Shelat, Elaine S Jaffe, et al.
International Journal of Laboratory Hematology|June 23, 2026
Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical ImplicationsWei Du, Shunsuke Koga, Guang Yang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 5, 2002
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biologyEdward J Gunther, George K Belka, Gerald B W Wertheim, et al.
American Journal of Clinical Pathology|January 18, 2015
Multifocal mantle cell lymphoma in situ in the setting of a composite lymphomaCaroline Sloan, Qun-Bin Xiong, Anne Crivaro, et al.
International Journal of Laboratory Hematology|April 26, 2024
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-relatedDong Chen, Julia Geyer, Adam Bagg, et al.
American Journal of Hematology|November 1, 2002
Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?Lorinda Soma, Dennis B Cornfield, David Prager, et al.
British Journal of Haematology|October 4, 2007
Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibresDavid J Kuter, Barbara Bain, Ghulam Mufti, et al.
Blood|April 19, 2003
Survival of acute myeloid leukemia cells requires PI3 kinase activationQing Xu, Serge-Emile Simpson, Timothy J Scialla, et al.
Expert Review of Anticancer Therapy|March 17, 2023
Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangementCraig W Freyer, Mitchell E Hughes, Alison Carulli, et al.
Pageof 18